Orban T I, Olah E
National Institute of Oncology, Department of Molecular Genetics, Budapest, H-1122, Hungary.
Mol Pathol. 2003 Aug;56(4):191-7. doi: 10.1136/mp.56.4.191.
Germline mutations of the BRCA1 gene predispose individuals mainly to the development of breast and/or ovarian cancer. However, the exact function of the gene is still unclear, although the encoded proteins are involved in various cellular processes, including transcriptional regulation and DNA repair pathways. Several BRCA1 splice variants are found in different tissues, but in spite of intense investigations, their regulation and possible functions are poorly understood at the moment. This review summarises current knowledge on the roles of these splice variants and the mechanisms responsible for their formation. Because alternative splicing is now widely accepted as an important source of genetic diversity, elucidating the functions of the BRCA1 splice variants would help in the understanding of the exact role(s) of this tumour suppressor. This should help to resolve the current paradox that, despite its seemingly vital cellular functions, mutations of this gene are associated with tissue specific tumour formation predominantly in the breast and the ovary.
BRCA1基因的种系突变主要使个体易患乳腺癌和/或卵巢癌。然而,尽管该基因编码的蛋白质参与包括转录调控和DNA修复途径在内的多种细胞过程,但其确切功能仍不清楚。在不同组织中发现了几种BRCA1剪接变体,尽管进行了深入研究,但目前对它们的调控和可能功能的了解仍然很少。这篇综述总结了关于这些剪接变体的作用以及其形成机制的当前知识。由于可变剪接现在已被广泛认为是遗传多样性的重要来源,阐明BRCA1剪接变体的功能将有助于理解这种肿瘤抑制因子的确切作用。这应该有助于解决当前的矛盾,即尽管该基因看似具有至关重要的细胞功能,但其突变却主要与乳腺和卵巢的组织特异性肿瘤形成相关。